# Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies

> **NCT07166744** · NA · NOT_YET_RECRUITING · sponsor: **University Hospital, Strasbourg, France** · enrollment: 286 (estimated)

## Conditions studied

- Dementia With Lewy Bodies (DLB)
- Alzheimer's Disease (AD)

## Interventions

- **OTHER:** Biological : blood sampling
- **OTHER:** nasopharyngeal swab
- **OTHER:** Procedure : Lumbar puncture
- **OTHER:** Behavioral : clinical, functional, cognitive and psychiatric evaluations
- **OTHER:** MRI

## Key facts

- **NCT ID:** NCT07166744
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2032-01-01
- **Final completion:** 2032-01-01
- **Target enrollment:** 286 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07166744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07166744, "Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07166744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*